BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29234122)

  • 21. Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity.
    Roth SH; Levanon EY; Eisenberg E
    Nat Methods; 2019 Nov; 16(11):1131-1138. PubMed ID: 31636457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multilayered control of exon acquisition permits the emergence of novel forms of regulatory control.
    Avgan N; Wang JI; Fernandez-Chamorro J; Weatheritt RJ
    Genome Biol; 2019 Jul; 20(1):141. PubMed ID: 31315652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DOT1L complex suppresses transcription from enhancer elements and ectopic RNAi in
    Esse R; Gushchanskaia ES; Lord A; Grishok A
    RNA; 2019 Oct; 25(10):1259-1273. PubMed ID: 31300558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unveiling the druggable RNA targets and small molecule therapeutics.
    Sztuba-Solinska J; Chavez-Calvillo G; Cline SE
    Bioorg Med Chem; 2019 May; 27(10):2149-2165. PubMed ID: 30981606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability.
    Jadaliha M; Gholamalamdari O; Tang W; Zhang Y; Petracovici A; Hao Q; Tariq A; Kim TG; Holton SE; Singh DK; Li XL; Freier SM; Ambs S; Bhargava R; Lal A; Prasanth SG; Ma J; Prasanth KV
    PLoS Genet; 2018 Nov; 14(11):e1007802. PubMed ID: 30496290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent mutation of the
    Annala M; Taavitsainen S; Vandekerkhove G; Bacon JVW; Beja K; Chi KN; Nykter M; Wyatt AW
    Commun Biol; 2018; 1():122. PubMed ID: 30272002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using Supervised Learning Methods for Gene Selection in RNA-Seq Case-Control Studies.
    Wenric S; Shemirani R
    Front Genet; 2018; 9():297. PubMed ID: 30123241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer.
    Wenric S; ElGuendi S; Caberg JH; Bezzaou W; Fasquelle C; Charloteaux B; Karim L; Hennuy B; Frères P; Collignon J; Boukerroucha M; Schroeder H; Olivier F; Jossa V; Jerusalem G; Josse C; Bours V
    Sci Rep; 2017 Dec; 7(1):17452. PubMed ID: 29234122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural Antisense Transcripts: Molecular Mechanisms and Implications in Breast Cancers.
    Latgé G; Poulet C; Bours V; Josse C; Jerusalem G
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-coding Natural Antisense Transcripts: Analysis and Application.
    Krappinger JC; Bonstingl L; Pansy K; Sallinger K; Wreglesworth NI; Grinninger L; Deutsch A; El-Heliebi A; Kroneis T; Mcfarlane RJ; Sensen CW; Feichtinger J
    J Biotechnol; 2021 Nov; 340():75-101. PubMed ID: 34371054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered antisense-to-sense transcript ratios in breast cancer.
    Maruyama R; Shipitsin M; Choudhury S; Wu Z; Protopopov A; Yao J; Lo PK; Bessarabova M; Ishkin A; Nikolsky Y; Liu XS; Sukumar S; Polyak K
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2820-4. PubMed ID: 21098291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-Wide Transcriptome Analysis of Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Positive Breast Cancers by Ribonucleic Acid Sequencing.
    Chen P; Song W; Liu L
    Gynecol Obstet Invest; 2018; 83(4):338-348. PubMed ID: 29241203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing.
    Guffanti A; Iacono M; Pelucchi P; Kim N; Soldà G; Croft LJ; Taft RJ; Rizzi E; Askarian-Amiri M; Bonnal RJ; Callari M; Mignone F; Pesole G; Bertalot G; Bernardi LR; Albertini A; Lee C; Mattick JS; Zucchi I; De Bellis G
    BMC Genomics; 2009 Apr; 10():163. PubMed ID: 19379481
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.